In summary, this is the first study to report that ncRNA-regulated FANCD2 in HCC plays a tumor-promoting role based on the starBase database, HCCDB, TIMER database, and GEPIA database, indicating that it can be employed as a potential prognostic marker. The gene discussed is FANCD2; the disease is hepatocellular carcinoma.